As ABCA4 malfunction applies to STGD, types of RP, cone-rod dystrophy, and age-related macular degeneration, gene therapies to deliver functional ABCA4 may also be useful in treating several other retinal diseases. This evidence concerns the gene ABCA4 and cone-rod dystrophy.